Methods and formulations for use in inhibiting conception and in treating benign gynecological disorders
US5340584A · kind A · utility
Assignee
Inventors
Key dates
| Filing date | Feb 1, 1993 |
| Grant date | Aug 23, 1994 |
| Priority date | — |
| Expiry date | Feb 1, 2013 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10S530/853
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Compositions and methods which are effective to inhibit conception and to treat benign gynecological disorders for extended periods of time are described, wherein an effective amount of a gonadotropin hormone releasing hormone composition and an effective amount of an estrogenic composition are provided over a first period of time, in addition to a progestogen and optionally an androgenic composition. According to one protocol, the progestogen is provided for a second, shorter period of time; the progestogen is provided at a higher level for at least 5 to about 20 days, and then at a lower level for the remainder, if any, of the second period of time. In an alternative protocol, the progestogen is provided at a lower level substantially throughout the period of administration of gonadotropin hormone releasing hormone composition and estrogenic composition. An effective amount of the androgenic hormone is optionally provided over the first period of time.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.